What does impairment of strategic investments mean?

Represents the impairment charges recognized on strategic investments or equity securities that lack a readily determinable fair value. This metric highlights potential risks or losses associated with the company's long-term investment portfolio.

USANA Health Sciences USNA Impairment of strategic investments

Impairment of strategic investments at other companies

Gray TelevisionGTN

$5M-20.0%

USANA Health SciencesUSNA

$0—

Energy Vault HoldingsNRGV

$0-100%

DiodesDIOD

$1.25M-78.5%

LivaNovaLIVN

$1.13M—

Schneider NationalSNDR

$4.9M—

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's impairment of strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's impairment of strategic investments?: USANA Health Sciences (USNA) reported impairment of strategic investments of $0 in Q1 2026.
What does impairment of strategic investments mean?: Represents the impairment charges recognized on strategic investments or equity securities that lack a readily determinable fair value. This metric highlights potential risks or losses associated with the company's long-term investment portfolio.